 |
VectorY Therapeutics
Last updated: October 12, 2024
Alexander Vos – CEO
Netherlands | Funding: €160M (+)
Website: https://www.vectorytx.com/
VectorY Therapeutics develops gene therapies against amyotrophic lateral sclerosis (ALS) and Alzhiemer’s disease.
Website: https://www.vectorytx.com/
VectorY Therapeutics develops gene therapies against amyotrophic lateral sclerosis (ALS) and Alzhiemer’s disease.
